Skystar Bio-Pharmaceutical Co (FRA:GNJC) Interest Expense : €-0.39 Mil (TTM As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Skystar Bio-Pharmaceutical Co's interest expense for the three months ended in Sep. 2014 was € -0.20 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2014 was €-0.39 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Skystar Bio-Pharmaceutical Co's Operating Income for the three months ended in Sep. 2014 was € 4.19 Mil. Skystar Bio-Pharmaceutical Co's Interest Expense for the three months ended in Sep. 2014 was € -0.20 Mil. Skystar Bio-Pharmaceutical Co's Interest Coverage for the quarter that ended in Sep. 2014 was 21.38. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Skystar Bio-Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Interest Expense Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Interest Expense

Get a 7-Day Free Trial

-0.04

-0.05

-0.11

-0.58

-0.45

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Interest Expense	Get a 7-Day Free Trial															-0.12	-0.03	-0.06	-0.10	-0.20

Skystar Bio-Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.39 Mil.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Skystar Bio-Pharmaceutical Co's Interest Expense for the three months ended in Sep. 2014 was €-0.20 Mil. Its Operating Income for the three months ended in Sep. 2014 was €4.19 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2014 was €0.00 Mil.

Skystar Bio-Pharmaceutical Co's Interest Coverage for the quarter that ended in Sep. 2014 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2014 )	/	Interest Expense (Q: Sep. 2014 )
	=	-1	*	4.19	/	-0.196
	=	21.38

The higher the ratio, the stronger the company's financial strength is.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (FRA:GNJC) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Headlines

No Headlines